Literature DB >> 22992889

Ghrelin: a new treatment for non-alcoholic fatty liver disease?

Patric J D Delhanty, Aart J van der Lely.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22992889     DOI： 10.1007/s12020-012-9800-2

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  11 in total

1.  Is it appropriate to study blood ghrelin and obestatin in non-alcoholic fatty liver disease (NAFLD) without using protease inhibitors?

Authors:  Suleyman Aydin
Journal:  Ann Hepatol       Date:  2012 Jan-Feb       Impact factor: 2.400

2.  Association of obestatin, ghrelin, and inflammatory cytokines in obese patients with non-alcoholic fatty liver disease.

Authors:  Michael Estep; Massih Abawi; Mohammed Jarrar; Lei Wang; Maria Stepanova; Hazem Elariny; Amir Moazez; Zachary Goodman; Vikas Chandhoke; Ancha Baranova; Zobair M Younossi
Journal:  Obes Surg       Date:  2011-11       Impact factor: 4.129

Review 3.  Management of nonalcoholic steatohepatitis: an evidence-based approach.

Authors:  Suzanne E Mahady; Jacob George
Journal:  Clin Liver Dis       Date:  2012-06-20       Impact factor: 6.126

Review 4.  Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver.

Authors:  Toshinari Takamura; Hirofumi Misu; Tsuguhito Ota; Shuichi Kaneko
Journal:  Endocr J       Date:  2012-08-12       Impact factor: 2.349

5.  High ghrelin and obestatin levels and low risk of developing fatty liver.

Authors:  Ylse Gutierrez-Grobe; Israel Villalobos-Blasquez; Karla Sánchez-Lara; Antonio R Villa; Guadalupe Ponciano-Rodríguez; Martha H Ramos; Norberto C Chavez-Tapia; Misael Uribe; Nahum Méndez-Sánchez
Journal:  Ann Hepatol       Date:  2010 Jan-Mar       Impact factor: 2.400

6.  Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development.

Authors:  Yan Li; Jie Hai; Lake Li; Xuehui Chen; Hua Peng; Meng Cao; Qinggui Zhang
Journal:  Endocrine       Date:  2012-07-29       Impact factor: 3.633

7.  Liver transplantation in nonalcoholic steatohepatitis is associated with high mortality and post-transplant complications: a single-center experience.

Authors:  Matthias Heuer; Gernot M Kaiser; Alisan Kahraman; Mark Banysch; Fuat H Saner; Zoltan Mathé; Guido Gerken; Andreas Paul; Ali Canbay; Jürgen W Treckmann
Journal:  Digestion       Date:  2012-07-27       Impact factor: 3.216

8.  Unacylated ghrelin rapidly modulates lipogenic and insulin signaling pathway gene expression in metabolically active tissues of GHSR deleted mice.

Authors:  Patric J D Delhanty; Yuxiang Sun; Jenny A Visser; Anke van Kerkwijk; Martin Huisman; Wilfred F J van Ijcken; Sigrid Swagemakers; Roy G Smith; Axel P N Themmen; Aart-Jan van der Lely
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

9.  Ghrelin and leptin modulate immunity and liver function in overweight children.

Authors:  Yuki Okamatsu; Kentaro Matsuda; Ikue Hiramoto; Hidekazu Tani; Koichi Kimura; Yoichi Yada; Tatsuyuki Kakuma; Sadanobu Higuchi; Masayasu Kojima; Toyojiro Matsuishi
Journal:  Pediatr Int       Date:  2009-02       Impact factor: 1.524

Review 10.  Phenotyping the effect of diet on non-alcoholic fatty liver disease.

Authors:  Nicole J W de Wit; Lydia A Afman; Marco Mensink; Michael Müller
Journal:  J Hepatol       Date:  2012-07-11       Impact factor: 25.083
View more
  2 in total

Review 1.  Non-alcoholic fatty liver disease: a diabetologist's perspective.

Authors:  Joseph M Pappachan; Farrah A Antonio; Mahamood Edavalath; Arjun Mukherjee
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

2.  Circulating glucagon to ghrelin ratio as a determinant of insulin resistance in hyperthyroidism.

Authors:  Kemal Ağbaht; Murat Faik Erdogan; Rifat Emral; Nilgun Baskal; Sevim Güllü
Journal:  Endocrine       Date:  2013-04-10       Impact factor: 3.633
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.